Lv1
30 积分 2022-07-15 加入
Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study
5天前
已完结
Reactivation of pemphigus by varicella zoster virus after anti‐CD20 treatment
19天前
已完结
Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies
19天前
已完结
Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow‐up of the multicenter, single‐arm, Phase 2 study
30天前
已完结
Rechallenging with anti-PD-1 therapy in advanced renal cell carcinoma
1个月前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
1个月前
已完结
Real‐World Analysis of Treatment Patterns in Limited‐Stage Small Cell Lung Cancer: Implications for Clinical Practice
1个月前
已关闭
Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?
1个月前
已完结
Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China
1个月前
已完结
皖公网安备34019202002308
